Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Myomo, Inc. (MYO : AMEX)

• Company Description    Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. Number of Employees: 185

• Price / Volume Information    Yesterday's Closing Price: $0.91 Daily Weekly Monthly 20 Day Moving Average: 673,265 shares Shares Outstanding: 38.44 (millions) Market Capitalization: $34.98 (millions) Beta: 1.05 52 Week High: $7.17 52 Week Low: $0.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.78% -10.63% 12 Week -21.55% -22.82% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 45 Blue Sky Dr. Suite 101 - Burlington,MA 01803 USA ph: 617-996-9058 fax: - ir@myomo.com http://www.myomo.com

• General Corporate Information    Officers Paul R. Gudonis - Chief Executive Officer and Chairman David A. Henry - Chief Financial Officer Amy Knapp - Director Thomas A. Crowley, Jr. - Director Thomas F. Kirk - Director Peer Information Myomo, Inc. (BJCT) Myomo, Inc. (CADMQ) Myomo, Inc. (APNO) Myomo, Inc. (UPDC) Myomo, Inc. (IMTIQ) Myomo, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 62857J201 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/09/26 Share - Related Items Shares Outstanding: 38.44 Most Recent Split Date: 1.00 (0.03:1) Beta: 1.05 Market Capitalization: $34.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.29 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.35 Price/Cash Flow: - Price / Sales: 0.84 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: 18.18% Sales Growth vs. Year Ago Period: 9.59% vs. Previous Quarter: 4.55% ROE 12/31/25 - - 09/30/25 - -61.14 06/30/25 - -50.87 ROA 12/31/25 - - 09/30/25 - -30.85 06/30/25 - -27.00 Current Ratio 12/31/25 - - 09/30/25 - 2.49 06/30/25 - 2.39 Quick Ratio 12/31/25 - - 09/30/25 - 2.10 06/30/25 - 2.03 Operating Margin 12/31/25 - - 09/30/25 - -28.86 06/30/25 - -22.87 Net Margin 12/31/25 - - 09/30/25 - -28.86 06/30/25 - -22.87 Pre-Tax Margin 12/31/25 - - 09/30/25 - -27.65 06/30/25 - -21.76 Book Value 12/31/25 - - 09/30/25 - 0.39 06/30/25 - 0.49 Inventory Turnover 12/31/25 - - 09/30/25 - 3.89 06/30/25 - 3.57 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.17 06/30/25 - 0.08 Debt-to-Capital 12/31/25 - - 09/30/25 - 14.18 06/30/25 - 7.03

Powered by Zacks Investment Research ©